Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2025-12-24 @ 3:20 PM
NCT ID:
NCT01843192
Eligibility Criteria:
Inclusion Criteria:
* Suspected or confirmed NSCLC (up to and including Stage II)
* Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
* Performance status 0-1 (Eastern Cooperative Oncology Group classification)
* ASA score \< 3
* No prior history of VATS or open lung surgery
* Willing to give consent and comply with study-related evaluation and treatment schedule
Exclusion Criteria:
* Active bacterial infection or fungal infection;
* Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
* Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
* Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed)
* Pregnancy
* Physical or psychological condition which would impair study participation;
* The patient is judged unsuitable for study participation by the Investigator for any other reason; or
* Unable or unwilling to attend follow-up visits and examinations
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01843192
Study Brief:
Protocol Section:
NCT01843192